Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 165

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease

Open access
Abdelhamid, Asmaa S, Martin, Nicole, Bridges, Charlene, Brainard, Julii S, Wang, Xia, Brown, Tracey J, Hanson, Sarah, Jimoh, Oluseyi F, Ajabnoor, Sarah M, Deane, Katherine HO, Song, Fujian, Hooper, Lee · 2018 · Cochrane Database of Systematic Reviews

Abstract

BACKGROUND: Evidence on the health effects of total polyunsaturated fatty acids (PUFA) is equivocal. Fish oils are rich in omega-3 PUFA and plant oils in omega-6 PUFA. Evidence suggests that increasing PUFA-rich foods, supplements or supplemented foods can reduce serum cholesterol, but may increase body weight, so overall cardiovascular effects are unclear. OBJECTIVES: To assess effects of increasing total PUFA intake on cardiovascular disease and all-cause mortality, lipids and adiposity in adults. SEARCH METHODS: We searched CENTRAL, MEDLINE and Embase to April 2017 and clinicaltrials.gov and the World Health Organization International Clinical Trials Registry Platform to September 2016, without language restrictions. We checked trials included in relevant systematic reviews. SELECTION CRITERIA: We included randomised controlled trials (RCTs) comparing higher with lower PUFA intakes in adults with or without cardiovascular disease that assessed effects over 12 months or longer. We included full texts, abstracts, trials registry entries and unpublished data. Outcomes were all-cause mortality, cardiovascular disease mortality and events, risk factors (blood lipids, adiposity, blood pressure), and adverse events. We excluded trials where we could not separate effects of PUFA intake from other dietary, lifestyle or medication interventions. DATA COLLECTION AND ANALYSIS: Two review authors independently screened titles and abstracts, assessed trials for inclusion, extracted data, and assessed risk of bias. We wrote to authors of included trials for further data. Meta-analyses used random-effects analysis, sensitivity analyses included fixed-effects and limiting to low summary risk of bias. We assessed GRADE quality of evidence. MAIN RESULTS: We included 49 RCTs randomising 24,272 participants, with duration of one to eight years. Eleven included trials were at low summary risk of bias, 33 recruited participants without cardiovascular disease. Baseline PUFA intake was unclear in most trials, but 3.9% to 8% of total energy intake where reported. Most trials gave supplemental capsules, but eight gave dietary advice, eight gave supplemental foods such as nuts or margarine, and three used a combination of methods to increase PUFA.Increasing PUFA intake probably has little or no effect on all-cause mortality (risk 7.8% vs 7.6%, risk ratio (RR) 0.98, 95% confidence interval (CI) 0.89 to 1.07, 19,290 participants in 24 trials), but probably slightly reduces risk of coronary heart disease events from 14.2% to 12.3% (RR 0.87, 95% CI 0.72 to 1.06, 15 trials, 10,076 participants) and cardiovascular disease events from 14.6% to 13.0% (RR 0.89, 95% CI 0.79 to 1.01, 17,799 participants in 21 trials), all moderate-quality evidence. Increasing PUFA may slightly reduce risk of coronary heart disease death (6.6% to 6.1%, RR 0.91, 95% CI 0.78 to 1.06, 9 trials, 8810 participants) andstroke (1.2% to 1.1%, RR 0.91, 95% CI 0.58 to 1.44, 11 trials, 14,742 participants, though confidence intervals include important harms), but has little or no effect on cardiovascular mortality (RR 1.02, 95% CI 0.82 to 1.26, 16 trials, 15,107 participants) all low-quality evidence. Effects of increasing PUFA on major adverse cardiac and cerebrovascular events and atrial fibrillation are unclear as evidence is of very low quality.Increasing PUFA intake probably slightly decreases triglycerides (by 15%, MD -0.12 mmol/L, 95% CI -0.20 to -0.04, 20 trials, 3905 participants), but has little or no effect on total cholesterol (mean difference (MD) -0.12 mmol/L, 95% CI -0.23 to -0.02, 26 trials, 8072 participants), high-density lipoprotein (HDL) (MD -0.01 mmol/L, 95% CI -0.02 to 0.01, 18 trials, 4674 participants) or low-density lipoprotein (LDL) (MD -0.01 mmol/L, 95% CI -0.09 to 0.06, 15 trials, 3362 participants). Increasing PUFA probably has little or no effect on adiposity (body weight MD 0.76 kg, 95% CI 0.34 to 1.19, 12 trials, 7100 participants).Effects of increasing PUFA on serious adverse events such as pulmonary embolism and bleeding are unclear as the evidence is of very low quality. AUTHORS' CONCLUSIONS: This is the most extensive systematic review of RCTs conducted to date to assess effects of increasing PUFA on cardiovascular disease, mortality, lipids or adiposity. Increasing PUFA intake probably slightly reduces risk of coronary heart disease and cardiovascular disease events, may slightly reduce risk of coronary heart disease mortality and stroke (though not ruling out harms), but has little or no effect on all-cause or cardiovascular disease mortality. The mechanism may be via TG reduction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd012345.pub2

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Research works printed but not linked: 461

  1. Ahn, 2016, Effect of n-3 polyunsaturated fatty acids on regression of coronary atherosclerosis in statin treated patients undergoing percutaneous coronary intervention, Korean Circulation Journal, 46, 481, 10.4070/kcj.2016.46.4.481 · DOI
  2. Brouwer, 2013, Effect of alpha linolenic acid supplementation on serum prostate specific antigen (PSA): results from the Alpha Omega Trial, PloS One, 8, e81519, 10.1371/journal.pone.0081519 · DOI
  3. Eussen, 2012, Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction, European Heart Journal, 33, 1582, 10.1093/eurheartj/ehr499 · DOI
  4. Geleijnse, 2011, Effects of n-3 fatty acids on cognitive decline: a randomized double-blind, placebo-controlled trial in stable myocardial infarction patients, Alzheimer's & Dementia, 1, S512, 10.1016/j.jalz.2011.05.1432 · DOI
  5. Geleijnse, 2012, Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients, Alzheimer's & Dementia, 8, 278, 10.1016/j.jalz.2011.06.002 · DOI
  6. Geleijnse, 2010, Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: design and baseline characteristics of the Alpha Omega Trial, American Heart Journal, 159, 539, 10.1016/j.ahj.2009.12.033 · DOI
  7. Giltay, 2012, No effects of n-3 fatty acid supplementation on serum total testosterone levels in older men: the Alpha Omega Trial, International Journal of Andrology, 35, 680, 10.1111/j.1365-2605.2012.01255.x · DOI
  8. Giltay, 2011, Effects of n-3 fatty acids on depressive symptoms and dispositional optimism after myocardial infarction, American Journal of Clinical Nutrition, 94, 1442, 10.3945/ajcn.111.018259 · DOI
  9. Hoogeveen, 2012, Effects of n-3 fatty acids on decline of kidney function after myocardial infarction: Alpha Omega Trial, Nephrology, Dialysis, Transplantation, 27, ii64
  10. Hoogeveen, 2014, No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial, European Journal of Preventive Cardiology, 21, 1429, 10.1177/2047487313494295 · DOI
  11. Hoogeveen, 2014, Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial, Clinical Journal of The American Society of Nephrology: CJASN, 9, 1676, 10.2215/CJN.10441013 · DOI
  12. Kromhout, 2011, N-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes, Diabetes Care, 34, 2515, 10.2337/dc11-0896 · DOI
  13. Bassey, 2000, Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre- and postmenopausal women: two randomized controlled trials of Efacal v. calcium alone, British Journal of Nutrition, 83, 629, 10.1017/S0007114500000805 · DOI
  14. Bassey, 2000, Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre- and postmenopausal women: two randomized controlled trials of Efacal v. calcium alone, British Journal of Nutrition, 83, 629, 10.1017/S0007114500000805 · DOI
  15. Bates, 1977, Trial of polyunsaturated fatty acids in non-relapsing multiple sclerosis, British Medical Journal, 2, 932, 10.1136/bmj.2.6092.932-a · DOI
  16. Dworkin, 1984, Linoleic acid and multiple sclerosis: a reanalysis of three double-blind trials, Neurology, 34, 1441, 10.1212/WNL.34.11.1441 · DOI
  17. Bates, 1978, Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis, British Medical Journal, 2, 1390, 10.1136/bmj.2.6149.1390 · DOI
  18. Dworkin, 1984, Linoleic acid and multiple sclerosis: a reanalysis of three double-blind trials, Neurology, 34, 1441, 10.1212/WNL.34.11.1441 · DOI
  19. Bates, 1989, A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis, Journal of Neurology, Neurosurgery & Psychiatry, 52, 18, 10.1136/jnnp.52.1.18 · DOI · Paper page
  20. Black, 1995, Evidence that a low-fat diet reduces the occurrence of non-melanoma skin cancer, International Journal of Cancer, 62, 165, 10.1002/ijc.2910620210 · DOI
  21. Jaax, 1997, General guidelines for a low-fat diet effective in the management and prevention of nonmelanoma skin cancer, Nutrition and Cancer, 27, 150, 10.1080/01635589709514517 · DOI
  22. Brox, 2001, A long-term seal- and cod-liver-oil supplementation in hypercholesterolemic subjects, Lipids, 36, 7, 10.1007/s11745-001-0661-4 · DOI
  23. Burr, 1989, Fish and the heart, Lancet, ii, 1450
  24. Burr, 1989, Diet and reinfarction trial (DART): design, recruitment, and compliance, European Heart Journal, 10, 558, 10.1093/oxfordjournals.eurheartj.a059528 · DOI
  25. Burr, 1992, Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART), European Heart Journal, 13, 166, 10.1093/oxfordjournals.eurheartj.a060141 · DOI
  26. Burr, 1994, Diet and reinfarction [letter], European Heart Journal, 15, 1152, 10.1093/oxfordjournals.eurheartj.a060645 · DOI
  27. Fehily, 1989, The effect of dietary advice on nutrient intakes: evidence from the diet and reinfarction trial (DART), Journal of Human Nutrition & Dietetics, 2, 225, 10.1111/j.1365-277X.1989.tb00026.x · DOI
  28. Tokudome, 2015, Dietary n-3/long-chain n-3 polyunsaturated fatty acids for prevention of sporadic colorectal tumors: a randomized controlled trial in polypectomized participants, Prostaglandins, Leukotrienes, and Essential Fatty Acids, 94, 1, 10.1016/j.plefa.2014.09.001 · DOI
  29. Tokudome, 2002, Rationale and study design of dietary intervention in patients polypectomized for tumors of the colorectum, Japanese Journal of Clinical Oncology, 32, 550, 10.1093/jjco/hyf108 · DOI
  30. Doi, 2014, Clinical outcomes of early initiation of pure eicosapentaenoic acid supplement after percutaneous coronary intervention in patients with acute coronary syndrome, European Heart Journal, 35, 1156
  31. Doi, 2014, Early eicosapentaenoic acid treatment after percutaneous coronary intervention reduces acute inflammatory responses and ventricular arrhythmias in patients with acute myocardial infarction: a randomized, controlled study, International Journal of Cardiology, 176, 577, 10.1016/j.ijcard.2014.08.055 · DOI
  32. Nosaka, 2017, Early initiation of eicosapentaenoic acid and statin treatment is associated with better clinical outcomes than statin alone in patients with acute coronary syndromes: 1-year outcomes of a randomized controlled study, International Journal of Cardiology, 228, 173, 10.1016/j.ijcard.2016.11.105 · DOI · Paper page
  33. Nosaka, 2016, Early initiation of eicosapentaenoic acid and statin treatment is associated with better clinical outcomes than statin alone in patients with acute coronary syndromes: 1-year outcomes of a randomized controlled study, Journal of the American College of Cardiology, 67, 573, 10.1016/S0735-1097(16)30574-5 · DOI
  34. Dullaart, 1992, Long-term effects of linoleic-acid-enriched diet on albuminuria and lipid levels in type 1 (insulin-dependent) diabetic patients with elevated urinary albumin excretion, Diabetologia, 35, 165, 10.1007/BF00402550 · DOI
  35. Feagan, 2008, Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials, JAMA, 299, 1690, 10.1001/jama.299.14.1690 · DOI · Paper page
  36. Feagan, 2008, Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials, JAMA, 229, 1690, 10.1001/jama.299.14.1690 · DOI · Paper page
  37. Danthiir, 2011, The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults, Nutrition Journal, 10, 117, 10.1186/1475-2891-10-117 · DOI
  38. Danthiir, 2014, Cognitive performance in older adults is inversely associated with fish consumption but not erythrocyte membrane n-3 fatty acids, Journal of Nutrition, 144, 311, 10.3945/jn.113.175695 · DOI
  39. Keen, 1993, Treatment of diabetic neuropathy with gamma-linolenic acid, Diabetes Care, 16, 8, 10.2337/diacare.16.1.8 · DOI · Paper page
  40. Pasternak, 1996, Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial, Annals of Internal Medicine, 125, 529, 10.7326/0003-4819-125-7-199610010-00001 · DOI
  41. Sacks, 1994, Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients, Lancet, 344, 1182, 10.1016/S0140-6736(94)90506-1 · DOI · Paper page
  42. Sacks, 1995, Controlled trial of fish oil for regression of human coronary atherosclerosis, Journal of the American College of Cardiology, 25, 1492, 10.1016/0735-1097(95)00095-L · DOI · Paper page
  43. Tan, 2010, Dietary Manipulation and Weight Management [thesis]
  44. Houtsmuller, 1980, Influence of different diets on the progression of diabetic retinopathy, Progress in Food Nutritition and Science, 4, 41
  45. Kumar, 2012, Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion, Heart Rhythm, 9, 483, 10.1016/j.hrthm.2011.11.034 · DOI
  46. Kumar, 2013, Effects of long-term omega-3 polyunsaturated fatty acid supplementation on paroxysmal atrial tachyarrhythmia burden in patients with implanted pacemakers: results from a prospective randomised study, International Journal of Cardiology, 168, 3812, 10.1016/j.ijcard.2013.06.030 · DOI
  47. Swinburn, 1999, Effects of reduced-fat diets consumed ad libitum on intake of nutrients particularly antioxidant vitamins, Journal of the American Dietetic Association, 99, 1400, 10.1016/S0002-8223(99)00339-9 · DOI
  48. Al-Hilal, 2013, Genetic variation at the FADS1-FADS2 gene locus influences delta-5 desaturase activity and LC-PUFA proportions after fish oil supplement, Journal of Lipid Research, 54, 542, 10.1194/jlr.P032276 · DOI
  49. AlSaleh, 2014, Interaction between a CSK gene variant and fish oil intake influences blood pressure in healthy adults, Journal of Nutrition, 144, 267, 10.3945/jn.113.185108 · DOI
  50. Alsaleh, 2013, Adiponectin gene variant interacts with fish oil supplementation to influence serum adiponectin in older individuals, Journal of Nutrition, 143, 1021, 10.3945/jn.112.172585 · DOI
  51. Hall, 2013, Effect of low doses of long chain n-3 polyunsaturated fatty acids on sleep-time heart rate variability: a randomized, controlled trial, International Journal of Cardiology, 168, 4439, 10.1016/j.ijcard.2013.06.153 · DOI
  52. Pinto, 2015, Effect of low doses of long chain n-3 PUFA intake on daytime heart rate variability: results from the MARINA study, European Journal of Preventive Cardiology, 1, S146
  53. Proudman, 2012, Fish oil in rheumatoid arthritis: a randomised, double blind trial comparing high dose with low dose, Internal Medicine Journal, 42, 2
  54. Sanders, 2011, Effect of low doses of long-chain n-3 PUFAs on endothelial function and arterial stiffness: a randomized controlled trial, American Journal of Clinical Nutrition, 94, 973, 10.3945/ajcn.111.018036 · DOI
  55. McIllmurray, 1987, Controlled trial of gamma linolenic acid in Duke's C colorectal cancer, BMJ (Clinical Research Ed.), 294, 1260 (Erratum i, 10.1136/bmj.294.6582.1260 · DOI
  56. Mendis, 2001, Coconut fat and serum lipoproteins: effects of partial replacement with unsaturated fats, British Journal of Nutrition, 85, 583, 10.1079/BJN2001331 · DOI
  57. Mita, 2007, Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes, Atherosclerosis, 191, 162, 10.1016/j.atherosclerosis.2006.03.005 · DOI
  58. Ederer, 1971, Cancer among men on cholesterol lowering diets: experience of five clinical trials, Lancet, 2, 203, 10.1016/S0140-6736(71)90911-1 · DOI
  59. Heady, 1974, Are PUFA harmful?, British Medical Journal, 1, 115, 10.1136/bmj.1.5898.115-c · DOI
  60. Baker, 1963, The National Diet-Heart Study: an initial report, JAMA, 185, 105, 10.1001/jama.1963.03060020065024 · DOI
  61. Brown, 1968, The National Diet Heart Study - implications for dietitians and nutritionists, Journal of the American Dietetic Association, 52, 279, 10.1016/S0002-8223(21)12151-0 · DOI
  62. Ederer, 1971, Cancer among men on cholesterol-lowering diets: experience from five clinical trials, Lancet, 298, 203, 10.1016/S0140-6736(71)90911-1 · DOI
  63. Page, 1968, Some observations on the National Diet-Heart Study, Circulation, 37, 313, 10.1161/01.CIR.37.3.313 · DOI
  64. Baker, 1963, The National Diet-Heart Study: an initial report, JAMA, 185, 105, 10.1001/jama.1963.03060020065024 · DOI
  65. Brown, 1968, The National Diet Heart Study - implications for dietitians and nutritionists, Journal of the American Dietetic Association, 52, 279, 10.1016/S0002-8223(21)12151-0 · DOI
  66. Ederer, 1971, Cancer among men on cholesterol-lowering diets: experience from five clinical trials, Lancet, 298, 203, 10.1016/S0140-6736(71)90911-1 · DOI
  67. Page, 1968, Some observations on the National Diet-Heart Study, Circulation, 37, 313, 10.1161/01.CIR.37.3.313 · DOI
  68. Nodari, 2011, N-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study, Circulation, 124, 1100, 10.1161/CIRCULATIONAHA.111.022194 · DOI
  69. Nodari, 2010, Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in heart failure patients, European Heart Journal, 31, 850
  70. Nodari, 2011, Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy, Journal of the American College of Cardiology, 57, 870, 10.1016/j.jacc.2010.11.017 · DOI · Paper page
  71. Nodari, 2012, Plasma levels of n-3 polyunsaturated fatty acids and risk of hospitalization in patients with non-ischemic cardiomyopathy, Circulation, 126, 17431
  72. Ilsey, 1987, Randomised placebo controlled trial of MAXEPA and aspirin/persantin after successful coronary angioplasty, Australian & New Zealand Journal of Medicine, 17, 559
  73. Nye, 1990, Effect of eicosapentaenoic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronary angioplasty, Australian and New Zealand Journal of Medicine, 20, 549, 10.1111/j.1445-5994.1990.tb01311.x · DOI
  74. Tatsuno, 2013, Long-term safety and efficacy of TAK-085 in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: the omega-3 fatty acids randomized long-term (ORL) study, Journal of Clinical Lipidology, 7, 615, 10.1016/j.jacl.2013.09.002 · DOI
  75. Babio, 2014, Mediterranean diets and metabolic syndrome status in the PREDIMED randomized trial, CMAJ Canadian Medical Association Journal, 186, E649, 10.1503/cmaj.140764 · DOI · Paper page
  76. Barcelo, 2009, Mediterranean-style diet effect on the structural properties of the erythrocyte cell membrane of hypertensive patients: the Prevencion con Dieta Mediterranea Study, Hypertension, 54, 1143, 10.1161/HYPERTENSIONAHA.109.137471 · DOI
  77. Bullo, 2009, Mediterranean diet and high dietary acid load associated with mixed nuts: effect on bone metabolism in elderly subjects, Journal of the American Geriatrics Society, 57, 1789, 10.1111/j.1532-5415.2009.02481.x · DOI
  78. Casas, 2014, The effects of the Mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial, PloS One, 9, e100084, 10.1371/journal.pone.0100084 · DOI · Paper page
  79. Casas, 2013, Inhibition of circulating immune cells related to atherogenesis intervention after 1, 3 and 5 years with Mediterranean diet, Annals of Nutrition and Metabolism, 62, 43
  80. Cohen, 2013, The association between obesity status and long-term adherence to Mediterranean diet in the PREDIMED trial, Circulation, 127, AP098
  81. Damasceno, 2013, Mediterranean diet supplemented with nuts reduces waist circumference and shifts lipoprotein subfractions to a less atherogenic pattern in subjects at high cardiovascular risk, Atherosclerosis, 230, 347, 10.1016/j.atherosclerosis.2013.08.014 · DOI · Paper page
  82. Domenech, 2010, Effect of the Mediterranean diet on blood pressure: the ambulatory blood pressure substudy (Predimed-ABPM), Journal of Hypertension, 28, e373, 10.1097/01.hjh.0000379349.42484.74 · doi:10.1097/01.hjh.0000379349.42484.74
  83. Domenech, 2014, Mediterranean diet reduces 24-hour ambulatory blood pressure, blood glucose, and lipids: one-year randomized, clinical trial, Hypertension, 64, 69, 10.1161/HYPERTENSIONAHA.113.03353 · DOI · Paper page
  84. Razquin, 2009, A 3 years follow-up of a Mediterranean diet rich in virgin olive oil is associated with high plasma antioxidant capacity and reduced body weight gain, European Journal of Clinical Nutrition, 63, 1387, 10.1038/ejcn.2009.106 · DOI · Paper page
  85. Ruiz-Canela, 2014, Association of Mediterranean diet with peripheral artery disease: the PREDIMED randomized trial, JAMA, 311, 415, 10.1001/jama.2013.280618 · DOI · Paper page
  86. Sala-Vila, 2014, Changes in ultrasound-assessed carotid intima-media thickness and plaque with a Mediterranean diet: a substudy of the PREDIMED trial, Arteriosclerosis, Thrombosis & Vascular Biology, 34, 439, 10.1161/ATVBAHA.113.302327 · DOI
  87. Sola, 2011, Effect of a traditional Mediterranean diet on apolipoproteins B, A-I, and their ratio: a randomized, controlled trial, Atherosclerosis, 218, 174, 10.1016/j.atherosclerosis.2011.04.026 · DOI
  88. Valls-Pedret, 2015, Mediterranean diet and age-related cognitive decline: a randomized clinical trial, JAMA Internal Medicine, 175, 1094, 10.1001/jamainternmed.2015.1668 · DOI · Paper page
  89. Proudman, 2012, Fish oil in rheumatoid arthritis: a randomised, double blind trial comparing high dose with low dose, Internal Medicine Journal, 42, 2
  90. Proudman, 2015, Plasma n-3 fatty acids and clinical outcomes in recent-onset rheumatoid arthritis, British Journal of Nutrition, 114, 885, 10.1017/S0007114515002718 · DOI
  91. Proudman, 2015, Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use, Annals of the Rheumatic Diseases, 74, 89, 10.1136/annrheumdis-2013-204145 · DOI · Paper page
  92. ISRCTN79170611 A multicentre, multinational, double blind, randomised, parallel group, placebo-controlled study of ethyl-eicosapentaenoate (EPA) in patients with Huntington's disease (HD) doi.org/10.1186/ISRCTN79170611 · doi:10.1186/isrctn79170611
  93. Puri, 2005, Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial, Neurology, 65, 286, 10.1212/01.wnl.0000169025.09670.6d · DOI
  94. Rose, 1965, Corn oil in treatment of ischaemic heart diseases, British Medical Journal, 1, 1531, 10.1136/bmj.1.5449.1531 · DOI · Paper page
  95. Myrup, 2001, Lack of effect of fish oil supplementation on coagulation and transcapillary escape rate of albumin in insulin-dependent diabetic patients with diabetic nephropathy, Scandinavian Journal of Clinical & Laboratory Investigation, 61, 349, 10.1080/003655101316911387 · DOI
  96. Rossing, 1996, Fish oil in diabetic nephropathy, Diabetes Care, 19, 1214, 10.2337/diacare.19.11.1214 · DOI
  97. Djuric, 1991, Effects of a low fat diet on levels of oxidative damage to DNA in human peripheral nucleated blood cells, Journal of the National Cancer Institute, 83, 766, 10.1093/jnci/83.11.766 · DOI · Paper page
  98. Djuric, 1994, Dietary modulation of oxidative DNA damage, Advances In Experimental Medicine and Biology, 354, 71, 10.1007/978-1-4899-0939-8_5 · DOI
  99. Kasim, 1993, Dietary and anthropometric determinants of plasma lipoproteins during a long-term low-fat diet in healthy women, American Journal of Clinical Nutrition, 57, 146, 10.1093/ajcn/57.2.146 · DOI
  100. Simon, 1997, A randomised trial of a low-fat dietary intervention in women at high risk for breast cancer, Nutrition and Cancer, 27, 136, 10.1080/01635589709514515 · DOI
  101. Blacket, 1979, The synergistic effect of weight loss and changes in dietary lipids on the serum cholesterol of obese men with hypercholesterolaemia: implications for prevention of coronary heart disease, Australian and New Zealand Journal of Medicine, 9, 521, 10.1111/j.1445-5994.1979.tb03388.x · DOI
  102. Ramsden, 2013, Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis, BMJ, 346, e8707 (Erratum, 10.1136/bmj.e8707 · DOI · Paper page
  103. Woodhill, 1978, Low fat, low cholesterol diet in secondary prevention of coronary heart disease, Advances in Experimental Medicine and Biology, 109, 317, 10.1007/978-1-4684-0967-3_18 · DOI · Paper page
  104. Dayton, 1966, Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat, Journal of Lipid Research, 7, 103, 10.1016/S0022-2275(20)39591-2 · DOI · Paper page
  105. Dayton, 1967, Adipose tissue linoleic acid as a criterion of adherence to a modified diet, Journal of Lipid Research, 8, 508, 10.1016/S0022-2275(20)38909-4 · DOI
  106. Dayton, 1965, Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man, Circulation, 32, 911, 10.1161/01.CIR.32.6.911 · DOI
  107. Dayton, 1965, Vitamin E status of humans during prolonged feeding of unsaturated fats, Journal of Laboratory and Clinical Medicine, 65, 739
  108. Dayton, 1970, Diet and atherosclerosis, Lancet, 1, 473, 10.1016/S0140-6736(70)90868-8 · DOI
  109. Dayton, 1969, Diet and cardiovascular diseases, Lancet, 1, 51, 10.1016/S0140-6736(69)91010-1 · DOI
  110. Dayton, 1969, Diet high in unsaturated fat: a controlled clinical trial, Minnesota Medicine, 1969, 1237
  111. Dayton, 1969, Prevention of coronary heart disease and other complications of atherosclerosis by modified diet, American Journal of Medicine, 46, 751, 10.1016/0002-9343(69)90026-6 · DOI
  112. Dayton, 1968, Trial of unsaturated-fat diet, Lancet, 2, 1296, 10.1016/S0140-6736(68)91783-2 · DOI
  113. Dayton, 1968, Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications, Lancet, 2, 1060, 10.1016/S0140-6736(68)91531-6 · DOI · Paper page
  114. Dayton, 1962, A controlled clinical trial of a diet high in unsaturated fat, New England Journal of Medicine, 266, 1017, 10.1056/NEJM196205172662001 · DOI · Paper page
  115. Ederer, 1971, Cancer among men on cholesterol-lowering diets: experience from five clinical trials, Lancet, 298, 203, 10.1016/S0140-6736(71)90911-1 · DOI
  116. Hiscock, 1962, A palatable diet high in unsaturated fat, Journal of the American Dietetic Association, 40, 427, 10.1016/S0002-8223(21)15876-6 · DOI
  117. Pearce, 1971, Incidence of cancer in men on a diet high in polyunsaturated fat, Lancet, 1, 464, 10.1016/S0140-6736(71)91086-5 · DOI · Paper page
  118. Sturdevant, 1973, Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet, New England Journal of Medicine, 288, 24, 10.1056/NEJM197301042880106 · DOI · Paper page
  119. Tompkins, 1964, Effect of long-term feeding of various fats on whole blood clotting times in men, Journal of Laboratory and Clinical Medicine, 64, 763
  120. Nandakumar, 2014, Coconut oil vs sunflower oil in atherosclerosis: challenges in dietary intervention, Indian Heart Journal, 66, S11, 10.1016/j.ihj.2014.10.030 · DOI
  121. Vijayakumar, 2014, What oil in patients with established coronary artery disease: outcomes of two year dietary intervention with coconut oil & sunflower oil, Indian Heart Journal, 66, S12, 10.1016/j.ihj.2014.10.033 · DOI
  122. Bitok, 2017, Favourable nutrient intake and displacement with long-term walnut supplementation among elderly: results of a randomised trial, British Journal of Nutrition, 118, 201, 10.1017/S0007114517001957 · DOI
  123. Bitok, 2016, Does a daily walnut supplement given for a year result in body weight gain?, FASEB Journal, 30, 1157
  124. Huey L Bitok E Kazzi N Sirirat R Haddad Tabrizi S Ros E Dietary compliance of walnut or no walnut intake in a 1-year randomized intervention trial among free-living elderly in the Walnuts and Healthy Aging Study (WAHA) FASEB Journal 2016 1157.10 · DOI
  125. Rajaram, 2016, The Walnuts and Healthy Aging Study (WAHA): protocol for a nutritional intervention trial with walnuts on brain aging, Frontiers in Aging Neuroscience, 8, 333
  126. Ros, 2016, Effect of a 1-year walnut supplementation on blood lipids among older individuals: findings from the walnuts and healthy aging (WAHA) study, FASEB Journal, 30, 293
  127. Bhatia, 2016, Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression, Atherosclerosis, 246, 13, 10.1016/j.atherosclerosis.2015.12.028 · DOI
  128. Byrne, 2014, Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease, Arteriosclerosis, Thrombosis, and Vascular Biology, 34, 1155, 10.1161/ATVBAHA.114.303034 · DOI · Paper page
  129. Byrne CD Targher G Time to replace assessment of liver histology with MR-based imaging tests to assess efficacy of interventions for nonalcoholic fatty liver disease Gastroenterology 2016 7 10 · DOI
  130. Clough, 2016, Higher body fat percentage is associated with enhanced temperature perception in NAFLD: results from the randomised Wessex Evaluation of fatty Liver and Cardiovascular markers in NAFLD with OMacor thErapy trial (WELCOME) trial, Diabetologia, 59, 1422, 10.1007/s00125-016-3966-8 · DOI
  131. McCormick, 2015, Impact of high dose n-3 polyunsaturated fatty acid treatment on measures of microvascular function and vibration perception in non-alcoholic fatty liver disease: results from the randomised WELCOME trial, Diabetologia, 58, 1916, 10.1007/s00125-015-3628-2 · DOI
  132. Scorletti, 2014, Design and rationale of the WELCOME trial: a randomised, placebo controlled study to test the efficacy of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease, Contemporary Clinical Trials, 37, 301-11 (Erratum, 10.1016/j.cct.2014.02.002 · DOI
  133. Scorletti, 2015, Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: results from the WELCOME trial, Journal of Hepatology, 63, 1476, 10.1016/j.jhep.2015.07.036 · DOI
  134. Targher, 2013, Clinical review: nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications, Journal of Clinical Endocrinology and Metabolism, 98, 483, 10.1210/jc.2012-3093 · DOI · Paper page
  135. Chlebowski, 1993, Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study, Journal of Clinical Oncology, 11, 2072, 10.1200/JCO.1993.11.11.2072 · DOI
  136. Chlebowski, 2006, Dietary fat reduction and breast cancer outcome: interim efficacy results from the women's intervention nutrition study, JNCI Journal of the National Cancer Institute, 98, 1767, 10.1093/jnci/djj494 · DOI · Paper page
  137. Chlebowski, 1990, Dietary fat reduction in adjuvant breast cancer therapy: current rationale and feasibility issues, Adjuvant. The Cancer Journal, 6, 357
  138. Hoy, 2009, Implementing a low-fat eating plan in the Women's Intervention Nutrition Study, Journal of the American Dietetic Association, 109, 688, 10.1016/j.jada.2008.12.016 · DOI
  139. Rose, 1992, Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients, Cancer Research, 52, 5386
  140. Rose, 1993, The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients, Breast Cancer Research & Treatment, 27, 253, 10.1007/BF00665695 · DOI
  141. Wynder, 1997, The challenges of assessing fat intake in cancer research investigations, Journal of the American Dietetic Association, 97, S5, 10.1016/S0002-8223(97)00723-2 · DOI
  142. Nigam, 2014, Fish oil for the reduction of atrial fibrillation recurrence, inflammation, and oxidative stress, Journal of the American College of Cardiology, 64, 1441, 10.1016/j.jacc.2014.07.956 · DOI
  143. Nigam, 2013, Multicentre trial of fish oil for the reduction of atrial fibrillation recurrence, inflammation and oxidative stress: the Atrial Fibrillation Fish Oil Research Study, Canadian Journal of Cardiology, 1, S383, 10.1016/j.cjca.2013.07.658 · DOI
  144. Brouwer, 2013, Effect of alpha linolenic acid supplementation on serum prostate specific antigen (PSA): results from the alpha omega trial, PLoS One, 8, e81519, 10.1371/journal.pone.0081519 · DOI
  145. Eussen, 2012, Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction, European Heart Journal, 33, 1582, 10.1093/eurheartj/ehr499 · DOI
  146. Geleijnse, 2011, Effects of n-3 fatty acids on cognitive decline: a randomized double-blind, placebo-controlled trial in stable myocardial infarction patients, Alzheimer's & Dementia, 1, S512, 10.1016/j.jalz.2011.05.1432 · DOI
  147. Geleijnse, 2012, Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients, Alzheimer's & Dementia, 8, 278, 10.1016/j.jalz.2011.06.002 · DOI
  148. Geleijnse, 2010, Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: design and baseline characteristics of the Alpha Omega Trial, American Heart Journal, 159, 539, 10.1016/j.ahj.2009.12.033 · DOI
  149. Giltay, 2012, No effects of n-3 fatty acid supplementation on serum total testosterone levels in older men: the Alpha Omega Trial, International Journal of Andrology, 35, 680, 10.1111/j.1365-2605.2012.01255.x · DOI
  150. Giltay, 2011, Effects of n-3 fatty acids on depressive symptoms and dispositional optimism after myocardial infarction, American Journal of Clinical Nutrition, 94, 1442, 10.3945/ajcn.111.018259 · DOI
  151. Hoogeveen, 2012, Effects of n-3 fatty acids on decline of kidney function after myocardial infarction: Alpha Omega trial, Nephrology Dialysis Transplantation, 27, ii64
  152. Hoogeveen, 2014, No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega trial, European Journal of Preventive Cardiology, 21, 1429, 10.1177/2047487313494295 · DOI
  153. Hoogeveen, 2014, Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega trial, Clinical Journal of The American Society of Nephrology: CJASN, 9, 1676, 10.2215/CJN.10441013 · DOI
  154. Kromhout, 2011, N-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes, Diabetes Care, 34, 2515, 10.2337/dc11-0896 · DOI
  155. Kromhout, 2010, N-3 fatty acids and cardiovascular events after myocardial infarction, New England Journal of Medicine, 363, 2015, 10.1056/NEJMoa1003603 · DOI · Paper page
  156. Bonds, 2014, Effect of long-chain omega-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial, JAMA Internal Medicine, 174, 763, 10.1001/jamainternmed.2014.328 · DOI · Paper page
  157. Chew, 2012, The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1), Ophthalmology, 119, 2282, 10.1016/j.ophtha.2012.05.027 · DOI · Paper page
  158. Chew, 2014, In reply: making sense of the evidence from the age-related eye disease study 2 randomized clinical trial, JAMA Ophthalmology, 132, 1031, 10.1001/jamaophthalmol.2014.2009 · DOI
  159. Chew, 2013, Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4, JAMA Ophthalmology, 131, 843, 10.1001/jamaophthalmol.2013.4412 · DOI
  160. Huynh, 2014, Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5, Ophthalmology, 121, 1229, 10.1016/j.ophtha.2013.12.035 · DOI
  161. Bowman, 2012, ASCEND: design and baseline characteristics of a large randomised trial in diabetes, Diabetes, 61, A556
  162. Azadbakht, 2007, Better dietary adherence and weight maintenance achieved by a long-term moderate fat diet, British Journal of Nutrition, 97, 399, 10.1017/S0007114507328602 · DOI
  163. Baldassarre, 2006, Effect of n-3 fatty acids on carotid atherosclerosis and haemostasis in patients with combined hyperlipoproteinemia: a double-blind pilot study in primary prevention, Annals of Medicine, 38, 367, 10.1080/07853890600852880 · DOI
  164. Berson, 2004, Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment, Archives of Ophthalmology, 122, 1297, 10.1001/archopht.122.9.1297 · DOI · Paper page
  165. Berson, 2004, Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses, Archives of Ophthalmology, 122, 1306, 10.1001/archopht.122.9.1306 · DOI · Paper page
  166. Caldwell SH Argo CK Henry TD Lackner C Pramoonjago P Weltman AL Dissociated histological and metabolic effects of omega-e (3000 mg/d) versus placebo with both exercise and diet in a double-blind randomized controlled trial of NASH Journal of Hepatology 2011 S8 · DOI
  167. Ness, 2004, The long-term effect of dietary advice on the diet of men with angina: the diet and angina randomized trial, Journal of Human Nutrition and Dietetics, 17, 1, 10.1111/j.1365-277X.2004.00506.x · DOI
  168. Burr, 1991, Fatty fish and heart disease: a randomized controlled trial, World Review of Nutrition and Dietetics, 66, 306, 10.1159/000419300 · DOI
  169. Burr, 1989, Fish and the heart [letter], Lancet, ii, 1451
  170. Burr, 1989, Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART), Lancet, 2, 757, 10.1016/S0140-6736(89)90828-3 · DOI · Paper page
  171. Burr, 1989, Diet and reinfarction trial (DART): design, recruitment, and compliance, European Heart Journal, 10, 558, 10.1093/oxfordjournals.eurheartj.a059528 · DOI
  172. Burr, 1992, Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART), European Heart Journal, 13, 166, 10.1093/oxfordjournals.eurheartj.a060141 · DOI
  173. Burr, 1994, Diet and reinfarction [letter], European Heart Journal, 15, 1152, 10.1093/oxfordjournals.eurheartj.a060645 · DOI
  174. Fehily, 1991, Factors influencing compliance with dietary advice: the Diet and Reinfarction Trial (DART), Journal of Human Nutrition and Dietetics, 4, 33, 10.1111/j.1365-277X.1991.tb00074.x · DOI
  175. Fehily, 1989, The effect of dietary advice on nutrient intakes: evidence from the diet and reinfarction trial (DART), Journal of Human Nutrition & Dietetics, 2, 4235, 10.1111/j.1365-277X.1989.tb00026.x · DOI
  176. Ness, 1999, The long-term effect of advice to eat more fish on blood pressure in men with coronary disease: results from the diet and reinfarction trial, Journal of Human Hypertension, 13, 729, 10.1038/sj.jhh.1000913 · DOI
  177. Derosa, 2016, Effects of n-3 PUFAs on fasting plasma glucose and insulin resistance in patients with impaired fasting glucose or impaired glucose tolerance, BioFactors (Oxford, England), 42, 316, 10.1002/biof.1277 · DOI
  178. Deslypere, 1992, Influence of supplementation with n-3 fatty acids on different coronary risk factors in men: a placebo controlled study, Verhandelingen - Koninklijke Vlaamse Academie voor Geneeskunde van Belgie, 54, 189
  179. Katan, 1997, Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study, Journal of Lipid Research, 38, 2012, 10.1016/S0022-2275(20)37132-7 · DOI · Paper page
  180. Harrison, 2000, From pies to pilchards: dietary assistants increase consumption of oil rich fish, Journal of Epidemiology and Community Health, Suppl, 6
  181. Harrison, 2005, Is there a role for long-chain omega3 or oil-rich fish in the treatment of atrial fibrillation?, Medical Hypotheses, 64, 59, 10.1016/j.mehy.2004.06.016 · DOI
  182. Harrison, 2003, Using community-based dietary assistants to increase the intake of oil-rich fish among older people, European Journal of Public Health, 13, 105
  183. Berstad, 2003, Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1, Clinical Science, 105, 13, 10.1042/CS20020349 · DOI
  184. Ellingsen, 2008, Consumption of fruit and berries is inversely associated with carotid atherosclerosis in elderly men, British Journal of Nutrition, 99, 674-81 (Erratum, 10.1017/S0007114507832521 · DOI
  185. Ellingsen, 2009, Vitamin C consumption is associated with less progression in carotid intima media thickness in elderly men: a 3-year intervention study, Nutrition Metabolism & Cardiovascular Diseases, 19, 8, 10.1016/j.numecd.2008.01.006 · DOI
  186. Furenes, 2008, Long-term influence of diet and/or omega-3 fatty acids on matrix metalloproteinase-9 and pregnancy-associated plasma protein A in men at high risk of coronary heart disease, Scandinavian Journal of Clinical & Laboratory Investigation, 68, 177, 10.1080/00365510701663350 · DOI
  187. Hjerkinn, 2006, Effect of diet or very long chain omega-3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima-media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia, European Journal of Cardiovascular Prevention & Rehabilitation, 13, 325
  188. Hjerkinn, 2005, Influence of long-term intervention with dietary counselling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia, American Journal of Clinical Nutrition, 81, 583, 10.1093/ajcn/81.3.583 · DOI
  189. Lindman, 2004, The effects of long-term diet and omega-3 fatty acid supplementation on coagulation factor VII and serum phospholipids with special emphasis on the R353Q polymorphism of the FVII gene, Thrombosis & Haemostasis, 91, 1097, 10.1160/TH03-12-0773 · DOI
  190. Troseid, 2009, Serum levels of interleukin-18 are reduced by diet and n-3 fatty acid intervention in elderly high-risk men, Metabolism: Clinical & Experimental, 58, 1543, 10.1016/j.metabol.2009.04.031 · DOI · Paper page
  191. Troseid, 2009, Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia, Diabetes Care, 32, 486, 10.2337/dc08-1710 · DOI
  192. Berstad, 2003, Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1, Clinical Science, 105, 13, 10.1042/CS20020349 · DOI
  193. Eid, 2006, Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine, Nutrition & Metabolism, 3, 4, 10.1186/1743-7075-3-4 · DOI
  194. Eid, 2006, Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine, Nutrition and Metabolism, 3, 1, 10.1186/1743-7075-3-1 · DOI
  195. Einvik, 2010, The influence of long-term awareness of hyperlipidemia and of 3 years of dietary counseling on depression, anxiety, and quality of life, Journal of Psychosomatic Research, 68, 567, 10.1016/j.jpsychores.2009.11.004 · DOI
  196. Einvik, 2010, A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk, European Journal of Cardiovascular Prevention & Rehabilitation, 17, 588, 10.1097/HJR.0b013e328339cc70 · DOI
  197. Ellingsen, 2006, Follow-up of diet and cardiovascular risk factors 20 years after cessation of intervention in the Oslo Diet and Antismoking study, European Journal of Clinical Nutrition, 60, 378, 10.1038/sj.ejcn.1602327 · DOI
  198. Furenes, 2008, Long-term influence of diet and/or omega-3 fatty acids on matrix metalloproteinase-9 and pregnancy-associated plasma protein A in men at high risk of coronary heart disease, Scandinavian Journal of Clinical and Laboratory Investigation, 68, 177, 10.1080/00365510701663350 · DOI
  199. Hjerkinn, 2006, Effect of diet or very long chain omega-3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima-media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia, European Journal of Cardiovascular Prevention & Rehabilitation, 13, 325
  200. Hjerkinn, 2005, Influence of long-term intervention with dietary counseling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia, American Journal of Clinical Nutrition, 81, 583, 10.1093/ajcn/81.3.583 · DOI

200 of 461 shown

Cited by

See all 165

Metadata

Authors
Abdelhamid, A. S., Martin, N., Bridges, C., Brainard, J. S., Wang, X., Brown, T. J., Hanson, S., Jimoh, O. F., Ajabnoor, S. M., Deane, K. H., Song, F., & Hooper, L.
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2018-07-18
Volume
11
Pages
CD012345-CD012345
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
OpenAlex
W2884781685
Cited by
165
References
75
FWCI
15.52
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.